Bristol Myers Squibb (BMY) Enterprise Value (QoQ) (2009 - 2026)

Bristol Myers Squibb (BMY) Enterprise Value (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.77%
Dec 31, 2025 35.33%
Sep 30, 2025 -21.44%
Jun 30, 2025 -15.58%
Mar 31, 2025 -8.49%
Dec 31, 2024 -34.47%
Sep 30, 2024 -21.78%
Jun 30, 2024 31.35%
Mar 31, 2024 21.37%
Dec 31, 2023 -60.41%
Sep 30, 2023 12.13%
Jun 30, 2023 5.80%
Mar 31, 2023 -0.12%
Dec 31, 2022 -2.59%
Sep 30, 2022 31.92%
Jun 30, 2022 11.65%
Mar 31, 2022 11.85%
Dec 31, 2021 -8.43%
Sep 30, 2021 -20.83%
Jun 30, 2021 -0.33%